首页> 美国卫生研究院文献>Springer Open Choice >Expression of B7-H3 a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells Affects Against Recurrence-Free Survival in Breast Cancer Patients
【2h】

Expression of B7-H3 a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells Affects Against Recurrence-Free Survival in Breast Cancer Patients

机译:B7-H3的表达肿瘤免疫逃逸的潜在因素与调节性T细胞的数量对乳腺癌患者无复发生存的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIn the tumor microenvironment, factors inhibiting the targeting of cancer cells by activated T cells have recently been noted. B7-H3 belongs to the B7 superfamily of immune regulatory ligands and plays an important role in the adaptive immune response of co-inhibitory/stimulatory factors in regulating T cells. However, the degree to which B7-H3 directly affects tumor immune evasion mechanisms remains unclear, particularly in patients with breast cancer. Regulatory T cells (Tregs) are known as a key player in the inhibition of immune mechanisms. The present study demonstrated that expression of B7-H3 on tumor cells and the number of Tregs in the tumor microenvironment independently affected prognosis in breast cancer patients.
机译:背景技术在肿瘤微环境中,近来已经注意到抑制活化的T细胞靶向癌细胞的因子。 B7-H3属于免疫调节配体的B7超家族,在调节T细胞的共同抑制/刺激因子的适应性免疫应答中起重要作用。但是,B7-H3直接影响肿瘤免疫逃逸机制的程度仍不清楚,特别是在患有乳腺癌的患者中。调节性T细胞(Tregs)是抑制免疫机制的关键角色。本研究表明,B7-H3在肿瘤细胞上的表达和肿瘤微环境中Treg的数量独立影响乳腺癌患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号